VyvgartMeSH concept

https://www.has-sante.fr/jcms/p_3516768/fr/vyvgart-efgartigimod-alfa-myasthenie-auto-immune-generalisee
2024
false
false
false
France
evaluation of the transparency committee
Diffuse
myasthenia gravis, generalized
efgartigimod alfa
efgartigimod alfa
Pervasive
myasthenia gravis
Efgartigimod Alfa
Myasthenia Gravis
Vyvgart

---
https://www.has-sante.fr/jcms/p_3402357/fr/vyvgart-efgartigimod-alfa-myasthenie
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
efgartigimod alfa
orphan drug production
infusions, intravenous
drug therapy, combination
myasthenia gravis, generalized
myasthenia gravis
Acetylcholine receptor antibody (substance)
evaluation of the transparency committee
evaluation of the transparency committee
myasthenia gravis
efgartigimod alfa
efgartigimod alfa
Vyvgart

---
https://www.has-sante.fr/jcms/p_3359123/fr/vyvgart-efgartigimod-alfa-myasthenie-auto-immune-generalisee
https://www.has-sante.fr/jcms/p_3359140/fr/decision-n2022-0279/dc/sem-du-21-juillet-2022-du-college-de-la-haute-autorite-de-sante-portant-autorisation-d-acces-precoce-de-la-specialite-vyvgart
2022
false
false
false
France
insurance, health, reimbursement
treatment outcome
guidelines for drug use
drug therapy, combination
adult
Anti-acetylcholine receptor antibody positivity
infusions, intravenous
antibodies, monoclonal, humanized
efgartigimod alfa
evaluation of the transparency committee
myasthenia gravis
Vyvgart
efgartigimod alfa
myasthenia gravis, generalized

---
https://www.ema.europa.eu/en/medicines/human/EPAR/vyvgart
2022
false
false
false
Netherlands
French
English
treatment outcome
treatment outcome
syndication feed
syndication feed
summary of product characteristics
summary of product characteristics
package leaflet
package leaflet
drug evaluation
drug evaluation
Vyvgart
Vyvgart
efgartigimod alfa
efgartigimod alfa
efgartigimod alfa
efgartigimod alfa
orphan drug production
orphan drug production
drug approval
drug approval
europe
europe
myasthenia gravis, generalized
myasthenia gravis, generalized
myasthenia gravis
myasthenia gravis
adult
adult
infusions, intravenous
infusions, intravenous
fc receptor, neonatal
fc receptor, neonatal
product surveillance, postmarketing
product surveillance, postmarketing
Anti-acetylcholine receptor antibody positivity
Anti-acetylcholine receptor antibody positivity
drug interactions
drug interactions
pregnancy
pregnancy
breast feeding
breast feeding
efgartigimod alfa
efgartigimod alfa
drug evaluation, preclinical
drug evaluation, preclinical

---